| dc.contributor.author | Coban, A. Y. | |
| dc.contributor.author | Cayci, Y. Tanriverdi | |
| dc.contributor.author | Erturan, Z. | |
| dc.contributor.author | Durupinar, B. | |
| dc.date.accessioned | 2020-06-21T14:54:27Z | |
| dc.date.available | 2020-06-21T14:54:27Z | |
| dc.date.issued | 2009 | |
| dc.identifier.issn | 1120-009X | |
| dc.identifier.issn | 1973-9478 | |
| dc.identifier.uri | https://doi.org/10.1179/joc.2009.21.5.592 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/18417 | |
| dc.description | WOS: 000273027600017 | en_US |
| dc.description | PubMed: 19933053 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Taylor & Francis Ltd | en_US |
| dc.relation.isversionof | 10.1179/joc.2009.21.5.592 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Effects of Efflux Pump Inhibitors Phenyl-Arginine-beta-Naphthylamide and 1-(1-Naphthylmethyl)-Piperazine on the Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 21 | en_US |
| dc.identifier.issue | 5 | en_US |
| dc.identifier.startpage | 592 | en_US |
| dc.identifier.endpage | 594 | en_US |
| dc.relation.journal | Journal of Chemotherapy | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
